Switch peptides in statu nascendi:: Induction of conformational transitions relevant to degenerative diseases

被引:149
作者
Mutter, M [1 ]
Chandravarkar, A [1 ]
Boyat, C [1 ]
Lopez, J [1 ]
Dos Santos, S [1 ]
Mandal, B [1 ]
Mimna, R [1 ]
Murat, K [1 ]
Patiny, L [1 ]
Saucède, L [1 ]
Tuchscherer, G [1 ]
机构
[1] Swiss Fed Inst Technol, EPFL BCH, Inst Chem Sci & Engn, CH-1015 Lausanne, Switzerland
关键词
Alzheimer's disease; circular dichroism; protein folding; protein structures; switch peptides;
D O I
10.1002/anie.200454045
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
A novel concept for triggering conformational transitions, and thus changes in structure and function, in peptides with a switching element S provides intriguing perspectives for studying molecular processes (see scheme) that play a key role, for example, in early events of Alzheimer's disease.
引用
收藏
页码:4172 / 4178
页数:7
相关论文
共 93 条
  • [1] Pharmacological profiles of peptide drug candidates for the treatment of Alzheimer's disease
    Adessi, C
    Frossard, MJ
    Boissard, C
    Fraga, S
    Bieler, S
    Ruckle, T
    Vilbois, F
    Robinson, SM
    Mutter, M
    Banks, WA
    Soto, C
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (16) : 13905 - 13911
  • [2] Aggeli A, 2001, SELF-ASSEMBLING PEPTIDE SYSTEMS IN BIOLOGY, MEDICINE AND ENGINEERING, P1
  • [3] ALTMANN KH, 1986, INT J PEPT PROT RES, V27, P314
  • [4] Forming stable helical peptides using natural and artificial amino acids
    Andrews, MJI
    Tabor, AB
    [J]. TETRAHEDRON, 1999, 55 (40) : 11711 - 11743
  • [5] ARUNAN C, UNPUB
  • [6] Helix capping
    Aurora, R
    Rose, GD
    [J]. PROTEIN SCIENCE, 1998, 7 (01) : 21 - 38
  • [7] STRUCTURE-ACTIVITY-RELATIONSHIPS OF NEUROPEPTIDE-Y ANALOGS WITH RESPECT TO Y-1 AND Y-2 RECEPTORS
    BECKSICKINGER, AG
    JUNG, G
    [J]. BIOPOLYMERS, 1995, 37 (02) : 123 - 142
  • [8] Photolytic control of peptide self-assembly
    Bosques, CJ
    Imperiali, B
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2003, 125 (25) : 7530 - 7531
  • [10] BUNDGAARD H, 1989, Advanced Drug Delivery Reviews, V3, P39, DOI 10.1016/0169-409X(89)90004-5